Strains of enteroaggregative Escherichia coli (EAggEC) have been implicated in several studies as important agents of persistent diarrhea among infants in the developing world. We have previously shown that the aggregative adherence (AA) property of EAggEC is associated with the presence of a 60-MDa plasmid which confers AA when introduced into E. coli HB101. Here, we report the cloning of the AA determinant from EAggEC strain 17-2 into the 21.5-kb cosmid vector pCVD301. TnphoA mutagenesis of the AA cosmid clone pJPN31 implicated an AA region of approximately 12 kb. Transmission electron microscopy of HB101 (pJPN31) revealed the presence of bundle-forming fimbriae, which were absent in AA-TnphoA insertion mutants. The presence of these fimbriae, AA, and hemagglutination (HA) of human erythrocytes were all concurrently lost by single-insertion mutations. A 14-kDa protein was seen on polyacrylamide gel electrophoresis and Western blotting (immunoblotting) of surface shear preparations from fimbriated clones. Twelve of nineteen volunteers fed EAggEC 17-2 developed rises in antibodies to the 14-kDa protein as determined by Western blot. We have termed the cloned bundle-forming fimbriae aggregative adherence fimbriae I (AAF/I); positivity with a previously described EAggEC probe and human erythrocyte HA appear to correlate with the presence of AAF/I.
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Strains of enteroaggregative Escherichia coli (EAggEC) have been implicated as etiologic agents of infant gastroenteritis in the developing world (3, 4, 8, 22) , most prominently among cases which persist longer than 14 days. Persistent diarrhea accounts for a disproportionate share of diarrhearelated morbidity and mortality in indigent populations (6, 32, 36) .
EAggEC strains are characterized by aggregative adherence (AA) to HEp-2 cells, wherein bacteria are seen in "stacked brick" aggregates attaching to HEp-2 cells and, usually, to the glass surface between cells (22) . EAggEC strains carry a 60-MDa plasmid which confers AA and also encodes a heat-stable enterotoxin (called EAST) (26, 34) .
Several groups have described surface structures on EA ggEC which might account for the AA property. We previously identified rigid fimbriae on the surface of EAggEC strain 17-2; 6 of 40 EAggEC strains reacted with antibodies directed against this structure (34) . Old et al. reported that two EAggEC strains expressed a fibrillar adhesin which conferred hemagglutination (HA) of rodent and human erythrocytes (24) . Yamamoto et al., studying the adherence of EAggEC to intestinal explants, have also implicated a factor which confers HA of human erythrocytes (37) . The molecular structure of this factor, however, has not been described.
Here, we provide evidence that the plasmid-associated AA factor of prototype EAggEC strain 17-2 is a bundleforming fimbria which confers human erythrocyte HA. We further show that this factor appears to be immunogenic in * Corresponding author. volunteers and that human HA is common to other EAggEC strains from various geographic locations.
MATERIALS AND METHODS
Strains. Wild-type E. coli strains used in this study are from the collection of the Center for Vaccine Development. These isolates originate from various sites around the world, including Santiago, Chile; Lima, Peru; Armed Forces Research Institute of Medical Services, Thailand (courtesy of Peter Echeverria); Israel (courtesy of Dani Cohen); and Guadalajara, Mexico (courtesy of John Mathewson). The prototype EAggEC strain used for this study is E. coli 17-2 (serotype 03:H2), isolated from the diarrheal stool of an infant in Santiago, Chile (33) . This patient experienced watery diarrhea of unknown duration without gross blood in the stool. 17-2 harbors a 60-MDa plasmid (p17-2) which, when transformed into E. coli HB101, confers AA (31) and the production EAST (26) .
Genetic manipulations were performed with E. coli HB101
(mcrB mrr hsdS20[rB-mBa recA13 leuB6 ara-14 proA2 lacYl galK2 xyl-5 mtl-l rpsL20[Smr] supE44) (5). HB101 is rough and produces few type 1 pili. TnphoA carried on plasmid pRT733 was maintained in thepir-lysogenized strain E. coli SM10Apir as previously described (27, 30) . All strains were propagated on Luria agar (L agar) or in L broth at 37°C and were stored at -70°C in L broth supplemented with 15% glycerol. Selection for antibiotic resistance was performed on L-agar plates with the following antibiotic concentrations: tetracycline, 30 p.g/ml; ampicillin, 100 ,ug/ ml; kanamycin, 50 pLg/ml. Molecular cloning. Plasmid DNA for large-and small-scale preparations was extracted by the alkaline lysis method (1 [16] and confirmed by plate counts). Serial twofold dilutions of the bacterial suspension in PBS were prepared; 100 ,u of each dilution was mixed with an equal volume of a 3% (vol/vol) washed human type A erythrocyte suspension containing 1% D-mannose (Sigma Chemical) in PBS. The suspensions were briefly mixed in a 24-well tissue culture dish and allowed to stand at room temperature for 20 min. After this time, HA was evaluated under x400 magnification with an inverted microscope. Any HA discerned to be greater than that of a negative bacterium-free control was considered to be positive; the highest dilution of the bacterial suspension producing HA was recorded for each strain tested.
Inhibition of HA was performed by incubating serial twofold dilutions of antiserum in PBS with an equal volume of a washed bacterial suspension (108/ml) at room temperature for 20 min. A 100-,u portion of this preparation was mixed with 100 pA of the 3% erythrocyte-1% mannose suspension, and HA was assayed as described above.
HEp-2 adherence assay. The HEp-2 adherence assay was performed by the CVD method (33) , based on the initial protocol described by Cravioto et al. (7) . HEp-2 cells were grown overnight to 50% confluent monolayers on glass coverslips in 24-well tissue culture dishes. Spent medium was discarded, and 20 pA of overnight L-broth bacterial culture plus 1 ml of fresh Eagle's minimal essential medium (GIBCO/BRL) with 0.5% D-mannose was added to each well. The assay was incubated for 3 h at 37°C in 5% CO2. After incubation, cells were washed twice with PBS, fixed with 70% methanol for 5 min, and then stained with 10% Giemsa for 15 min. Coverslips were examined under oil immersion light microscopy for the characteristic stacked brick aggregation on HEp-2 cells and on the glass coverslip. All positive specimens displayed at least one aggregate of more than five bacteria per high-power field. This method, featuring a 3-h incubation without a change of tissue culture medium, has been shown to be optimal for the detection of the aggregative phenotype (33) .
DNA colony hybridization. We performed colony hybridization on a select group of E. coli strains, using the EAggEC probe described by Baudry et al. (2) . Blots were prepared by the colony lift technique previously published (11 (16) . One milliliter of this suspension in a 1.5-ml Eppendorf tube was subjected to vortexing in a VWR Vortex Genie (highest speed) for 5 min. Bacterial cells were pelleted at 10,000 x g for 1 min in an Eppendorf 4515C microcentrifuge. Supernatants were separated by 18% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Laemmli (15) , and proteins were visualized by silver staining (Bio-Rad Laboratories, Richmond, Calif.). Proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, N.H.) by the method of Towbin et al. (31) . Blots were blocked in PBS-0.5% Tween 20 (PBST) for 20 min and then incubated overnight at 4°C with primary antiserum diluted in PBST.
Blots were washed three times for 10 min each in PBST and incubated for 2 h in a 1:1,000 dilution of alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G or anti-human immunoglobulin G (Cappel Research Products, Durham, N.C.) in PBST. Binding of antibody was detected with BCIP (165 kLg/ml) and nitroblue tetrazolium (330 ,ug/ml) (NBT; Sigma Chemical) for 10 min at room temperature (14) . INFECT A surface shear preparation of HB101(pJPN31) was separated by 18% SDS-PAGE using a trough preparative comb, and the gel was transferred to nitrocellulose paper. Thin strips representing identical antigen preparations were cut from this blot for the analysis of volunteer antisera.
Antiserum preparation. New Zealand White male rabbits (1.5 kg) were inoculated intravenously with live bacteria in doses escalating from 106 to 1010 organisms at 3-day intervals for a total of 12 doses and then boosted intravenously with 1010 organisms 3 weeks later. Each inoculum was prepared fresh by harvesting overnight cultures of HB101(pJPN31) at 10,000 x g in an Eppendorf 4515C microcentrifuge for 1 min, washing them twice with PBS, and resuspending the pellet in 1.0 ml of sterile PBS at the appropriate concentration (determined by McFarland nephelometry). Two weeks after the completion of the immunization series, rabbits were bled to obtain serum.
Antiserum raised against HB101(pJPN31) was exhaustively absorbed with the TnphoA insertion mutant HB101 (pJPN32.26) (negative for AA, HA, autoagglutination, and PhoA expression). An HB101(pJPN32.26) overnight culture was harvested and resuspended in PBS to a concentration of approximately 10" cells per ml. HB101(pJPN31) antiserum (1 ml) was diluted 1:4 in PBS and then incubated with the bacterial suspension at 4°C with gentle shaking; the absorption was repeated until only faintly reactive bands were seen on Western blots of HB101(pJPN32.26) surface shear preparations, and no further diminution was produced by subsequent absorptions.
Volunteer sera were absorbed with E. coli HB101 lipooligosaccharide (LOS) antigen extracted by the hot waterphenol method (35) . Nitrocellulose paper strips were saturated in 15 p,g of LOS per ml of water and then preincubated for 2 h with volunteer sera diluted 1:100 in PBS. Two milliliters of the absorbed 1:100 dilution was then used as the primary antiserum in Western blot reactions of the HB101 (pJPN31) shear preparation strips described above.
To test for serologic cross-reactivity of HB101(pJPN31) antigens with other fimbrial colonization factors of E. coli, we performed Western blot analysis of HB101(pJPN31) shear preparations by using specific polyclonal antisera against enterotoxigenic E. coli fimbriae CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, and PCFO159:H4 and also against rigid fimbriae extracted from intact 17-2 (34) and enterohemorrhagic E. coli 933. The fimbrial antisera were prepared by the subcutaneous inoculation of rabbits with purified fimbriae according to published methods (14, 17 Demonstration of AA fimbriae by electron microscopy.
Since AA in the HEp-2 assay is consistently demonstrated by using static L-broth cultures, bacterial samples for electron microscopy examination were grown in this manner. When HB101(pJPN31) was examined by transmission electron microscopy, long, bundle-forming fimbriae were visualized (Fig. 2) (Fig. 3) . The predominant protein band of HB101 (pJPN31) had an apparent molecular mass of 14 kDa, yet this band was not visualized in HB1O1(pJPN32.26) preparations. Surface shear preparations were separated by SDS-PAGE, transferred to nitrocellulose paper, and reacted with the antifimbrial serum. The 14-kDa protein was again the predominant band in Western blots of HB1O1(pJPN31) preparations; the intensity of this band was greatly diminished in shear preparations of HB101(pJPN32.26), and the band was absent in HB101(pCVD301) shear preparations (Fig. 4) . The 14-kDa band was present in HB101(pJPN32.2) preparations (data not shown).
The 14-kDa band was not detected in Western blots using the rabbit preimmunization serum (Fig. 5A) . The reactivity of the absorbed rabbit antiserum against several high-molecular-weight bands could not be completely abolished (not apparent in Fig. 4) ; these high-molecular-weight bands were also present in Western blots using preimmunization rabbit serum and likely represent low-affinity antibodies against common E. coli antigens. 12 kDa which reacted with the rabbit antifimbrial serum but was very faint in HB101(pJPN31). One AA' HA-EAggEC strain, 069, exhibited a faintly reactive band which was slightly larger than that of the 14-kDa protein.
We reacted HB101(pJPN31) shear preparations with monospecific polyclonal antisera directed against several previously described enterotoxigenic E. coli fimbriae. We also employed antisera against a previously described putative fimbrial antigen of EAggEC strains (24) (a generous gift of D. C. Old) and against the 16-kDa subunit of the rigid EAggEC fimbriae described by Vial et al. (34) . These antisera failed to react with the 14-kDa protein (data not shown).
Detection of antibodies in volunteers fed 17-2. Only 1 of 19 volunteers who were fed 101" EAggEC 17-2 organisms experienced significant diarrhea, as evidenced by a liquid stool volume of 572 ml over 3 days. Nitrocellulose strips on which were immobilized HB101(pJPN31) shear preparations were separately incubated with prechallenge and 21-daypostchallenge serum samples from all 19 volunteers at a dilution of 1:100. Each sample was tested before and after absorption with immobilized HB101 LOS preparations. Figure 5 shows typical results of these Western blots. Before challenge, 13 of the 19 volunteers had evidence of antibodies that recognized the 14-kDa protein; 16 had antibodies after challenge. Nine serum samples which were positive before challenge showed marked increases in the intensity of the reaction to the 14-kDa band. The one volunteer who developed diarrhea had no anti-14-kDa antibody before challenge but showed a marked seroconversion detectable in postchallenge serum. Absorption of volunteer antiserum with HB101 LOS did not diminish the intensity of the reaction to the 14-kDa band. As a control, the sera of two volunteers who reacted to the 14-kDa protein were incubated with blots containing HB101(pJPN32.26) and HB101(pCVD301) shear preparations. There was no detectable 14-kDa protein in the Western blots of these preparations. Correlation of HA with EAggEC probe positivity. The EAggEC probe was initially shown to have 89% sensitivity for EAggEC isolates from Santiago, Chile (2) . In order to correlate probe positivity with HA of type A human erythrocytes, we analyzed 52 EAggEC strains of various serotypes from several sites around the world. We chose 36 which were positive with the EAggEC probe and 16 which were negative; 35 of these strains showed HA with human erythrocytes. HA of human erythrocytes correlated strongly with probe positivity (P < 0.0001 by Fisher's exact test). Of the 36 probe-positive strains, 34 were positive for HA; of the 16 probe-negative strains, 15 were HA-. The probe was therefore 97% sensitive and 88% specific for detecting hemagglutinating strains.
DISCUSSION
The pathogenic mechanism by which EAggEC strains cause acute and persistent diarrhea is as yet unclear, although several features are beginning to emerge. Vial et al. demonstrated a characteristic intestinal histopathology in the rabbit ligated intestinal loop which included prominent adherence of the bacteria to the mucosa with hemorrhage and disruption of the villous architecture (34) . The dramatic adherence of these organisms to each other and to the mucosal surface may contribute to their persistence in the human intestine; the hemorrhagic nature of the lesion is consistent with the fact that many children infected with EAggEC experience bloody diarrhea (4) .
We have previously reported that AA in EAggEC is plasmid associated (23) . Here, we provide data to suggest that the plasmid of 17-2 encodes bundle-forming fimbriae, which confer HA of human erythrocytes. Two observations provide evidence that these fimbriae are related to AA in 17-2. First, cloning of the AA phenotype and expression in HB101 is accompanied by electron microscopic visualization of these fimbriae. Second, TnphoA insertion in one region of the cloned DNA simultaneously abolishes AA, HA, autoagglutination in broth, and the expression of the fimbriae under the electron microscope.
Baudry et al. developed a DNA probe to detect EAggEC consisting of a 1-kb fragment from the 17-2 plasmid; this probe was initially reported to have a sensitivity of 89% and a specificity of 99% when compared with AA in the HEp-2 assay (2). The correlation of EAggEC probe positivity with human erythrocyte HA suggests that the probe is highly sensitive and specific for the presence of a single conserved adhesin. The fimbriae we have cloned likely represent this conserved adherence factor, which we term aggregative adherence fimbriae I (AAF/I). Two EAggEC strains were probe positive but HA negative. This may be due to the lack of expression of the aaf genes, as has been demonstrated for the diffuse adherence factor F1845 (20) . Of note, strain JM221, which was shown by Mathewson et al. to be pathogenic in volunteers (19) , has been recognized to be an EAggEC strain (33) . In this study, we have found that JM221 is probe and HA positive and also expresses the 14-kDa protein.
Our data suggest that a large proportion of EAggEC strains express AAF/I, as defined by HA and probe positivity. However, we have noted that the probe sequences derived by Baudry et al. (2) do not lie within the aaf region described here (21) . This suggests that plasmid p17-2 represents a family of conserved EAggEC plasmids, as suggested by Vial et al. (34) . Some EAggEC strains apparently exhibit AA by a different adhesin.
Insertion mutagenesis indicates that a region of approximately 12 kb (designated the aaf region) is necessary for the expression of AAF/I. This region encodes multiple genes, suggested by the fact that subelones carrying only segments of the aaf genes permit trans complementation of some TnphoA insertion mutants (21) . This is consistent with observations concerning other E. coli fimbriae, which require several genes for full expression (10) . The fact that the AA phenotype is altered but not lost upon insertion into one particular locus is also consistent with previous observations concerning E. coli fimbriae. Some accessory fimbrial genes are involved in the regulation, transport, or stabilization of fimbrial production (10) ; the absence of such genes may modify fimbrial expression without completely abolishing synthesis.
In the first description of the AA phenotype, published by our group, we highlighted the adherence of bacteria on the glass coverslip away from the surface of the HEp-2 cells.
Subsequently, we have observed that many EAggEC strains adhered more prominently to the cell itself but were still in the stacked brick configuration typical of EAggEC. This cell-specific pattern is typified by 17-2. Since the probe was derived from 17-2, we have seen that both SAA and NAA may be probe positive (21 HB101(pJPN32.26) . We conclude that this protein is probably the AAF/I fimbrial subunit because (i) the 14-kDa band is the predominant protein on shear preparations and is the appropriate size for a fimbrial subunit, (ii) the band is markedly decreased in TnphoA insertion mutants which lose AA and HA, (iii) antibodies against this band are not lost after absorption with HB101(pJPN32.26), (iv) the band is present in Western blots of the EAggEC parent 17-2, (v) polyclonal antiserum against the 14-kDa band inhibits HA, and (vi) most volunteers fed the 17-2 parent mount responses to the 14-kDa band. The 17-2 wild-type parent also exhibits a second protein, smaller than 14 kDa, which reacts with antifimbrial serum. This may represent the product of the processing of the fimbrial subunit, as has been reported for the toxin-coregulated pilus of Vibrio cholerae (25) . HB101(pJPN31) exhibits this smaller protein, but to a lesser degree than the parent.
Experiments with volunteer sera yielded potentially important results. Despite the fact that most volunteers did not exhibit significant diarrhea upon inoculation with 17-2, 12 of 19 showed rises in the level of antibody against the 14-kDa band after inoculation. Although Western blots are only semiquantitative, the uniform antigen preparation and the standard dilution of sera allowed us to draw inferences from marked differences in reaction intensity. The observation that 13 of 19 volunteers had preexisting antibodies suggests that the U.S. population may acquire immunity to AAF/I at an early age or may have antibodies against a cross-reacting antigen, a fact which may have contributed to the low attack rate. Evidence for a possible cross-reacting antigen is provided by the fact that EAggEC 069 and several other AAF/I-negative strains express a band on Western blots which reacts with the AAF/I antiserum despite being negative to the EAggEC probe and for HA. The morphology of AAF/I is somewhat similar to that of other bundle-forming fimbriae, including the bundle-forming pilus of enteropathogenic E. coli and the toxin-coregulated fimbriae of V. cholerae. A group of fimbriae that includes these two structures, the so-called type 4 fimbriae, share antigenic cross-reactivity (25) . Whether or not AAF/I belongs to this group is yet to be determined.
Most diarrheagenic E. coli fimbriae are optimally expressed on agar plates, most notably on CFA agar. Given that screening for fimbriae is generally done by using CFA agar-grown cells, new structures may be discovered when investigators examine organisms grown under other conditions. This approach led to the elucidation of the structure of the bundle-forming pilus (12) . Here, we have reproduced the observations of Yamamoto et al. (37) , who demonstrated that HA in EAggEC was maximal in L-broth cultures; we believe that this is due to enhanced expression of AAF/I in this medium. The expression of type 1 fimbriae is also maximal in L broth, yet the morphology of AAF/I is strikingly different.
Despite the fact that previous studies linking EAggEC to diarrhea have defined the organisms by the HEp-2 assay (3, 4, 8, 22) , we believe that AAF/I producers are likely to be important pathogens, since they have represented ca. 90% of the EAggEC in studies from Chile and India (21) . Insufficient data exist to determine whether or not probe-negative EAggEC strains are pathogenic. We are conducting further studies on the genetics, structure, and immunogenicity of AAF/I in the hope of using this structure as an immunogen in future vaccine constructions.
